World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
117
Citations
147151
World Ranking
4099
National Ranking
2247

John M. Lachin publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where John M. Lachin sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 411 publications — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

John M. Lachin D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where John M. Lachin sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 117 D-Index — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

John M. Lachin is affiliated with George Washington University in the United States. Their research primarily focuses on Medicine, with significant contributions in Biochemistry, Genetics, and Molecular Biology. Within medicine, Lachin's work centers on Endocrinology, Diabetes, and Metabolism, complemented by studies in Genetics, Cardiology and Cardiovascular Medicine, Surgery, and Molecular Biology.

Their research output extensively covers topics related to diabetes and its management. Key thematic areas include:

  • Diabetes Management and Research
  • Diabetes Treatment and Management
  • Diabetes and Associated Disorders
  • Pancreatic Function and Diabetes
  • Metabolism, Diabetes, and Cancer
  • Cardiovascular Function and Risk Factors
  • Diabetes, Cardiovascular Risks, and Lipoproteins

Lachin has contributed to multiple high-impact publications, with recent notable papers as follows:

  • "Risk Factors for Diabetic Peripheral Neuropathy and Cardiovascular Autonomic Neuropathy in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study," 2020, Diabetes
  • "Glycemia Reduction in Type 2 Diabetes - Glycemic Outcomes," 2022, New England Journal of Medicine
  • "Glycemia Reduction in Type 2 Diabetes - Microvascular and Cardiovascular Outcomes," 2022, New England Journal of Medicine
  • "Understanding Metabolic Memory: The Prolonged Influence of Glycemia During the Diabetes Control and Complications Trial (DCCT) on Future Risks of Complications During the Study of the Epidemiology of Diabetes Interventions and Complications (EDIC)," 2021, Diabetes Care
  • "Cognitive Performance Declines in Older Adults with Type 1 Diabetes: Results from 32 Years of Follow-up in the DCCT and EDIC Study," 2021, The Lancet Diabetes & Endocrinology

Frequent publication venues reflect the core of Lachin's research domains, with numerous papers published in:

  • Diabetes Care
  • Diabetes
  • UNC Libraries
  • New England Journal of Medicine
  • The Lancet Diabetes & Endocrinology

Lachin collaborates regularly with a set of coauthors, including:

  • Ionut Bebu
  • Barbara H. Braffett
  • Steven E. Kahn
  • Rose Gubitosi-Klug
  • Kieren J. Mather

Their scientific work intertwines clinical and molecular approaches across diabetes and related cardiovascular and genetic fields, bridging long-term metabolic studies with outcomes research. This is evidenced by involvement in major longitudinal trials such as the Diabetes Control and Complications Trial (DCCT) and Epidemiology of Diabetes Interventions and Complications (EDIC) Study, which explore glycemic control and its extended effects on diabetic complications and cognitive outcomes.

Best Publications

  • The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

    Diabetes Control;D M Nathan;S Genuth

  • Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin

    W. C. Knowler;E. Barrett-connor;S. E. Fowler;R. F. Hamman

  • Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

    Bernard Zinman;Christoph Wanner;John M. Lachin;David Fitchett

  • Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

    David M. Nathan;Patricia A. Cleary;Jye Yu C Backlund;Saul M. Genuth

  • Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.

    Kahn Se;Haffner Sm;Heise Ma;Herman Wh

  • Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

    Jennifer B Green;M. Angelyn Bethel;Paul W Armstrong;John B Buse

  • Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.

    Diabetes Control;Complications Trial

  • Effect of Weight Loss With Lifestyle Intervention on Risk of Diabetes

    Richard F. Hamman;Rena R. Wing;Sharon L. Edelstein;John M. Lachin

  • Introduction to sample size determination and power analysis for clinical trials.

    John M. Lachin

  • Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus.

    David M Nathan;John Lachin;Patricia Cleary;Trevor Orchard

  • Effects of insulin in relatives of patients with type 1 diabetes mellitus

    J. S. Skyler;D. Brown;H. P. Chase;E. Collier

  • Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

    Mark D. Pescovitz;Carla J. Greenbaum;Heidi Krause-Steinrauf;Dorothy J. Becker

  • Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial

    David Fitchett;Bernard Zinman;Bernard Zinman;Christoph Wanner;John M. Lachin

  • Statistical considerations in the intent-to-treat principle.

    John M. Lachin

  • Differences in A1C by Race and Ethnicity Among Patients With Impaired Glucose Tolerance in the Diabetes Prevention Program

    William H. Herman;Yong Ma;Gabriel Uwaifo;Steven Haffner

  • Rosiglitazone-associated Fractures in Type 2 Diabetes: An Analysis From A Diabetes Outcome Progression Trial (ADOPT)

    Steven E. Kahn;Bernard Zinman;John M. Lachin;Steven M. Haffner

  • Achieving weight and activity goals among diabetes prevention program lifestyle participants.

    Rena R Wing;Richard F Hamman;George A Bray;Linda Delahanty

  • Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes

    Ian H. De Boer;Wanjie Sun;Patricia A. Cleary;John M. Lachin

  • How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial

    Silvio E Inzucchi;Bernard Zinman;David Fitchett;Christoph Wanner

  • Rituximab, B-lymphocyte depletion, and preservation of beta-cell function

    Mark D. Pescovitz;Carla J. Greenbaum;Heidi Krause-Steinrauf;Dorothy J. Becker

Frequent Co-Authors

David M. Nathan
David M. Nathan Harvard University
Bernard Zinman
Bernard Zinman University of Toronto
William H. Herman
William H. Herman University of Michigan–Ann Arbor
Trevor J. Orchard
Trevor J. Orchard University of Pittsburgh
Michael W. Steffes
Michael W. Steffes University of Minnesota
Steven E. Kahn
Steven E. Kahn University of Washington
Rury R. Holman
Rury R. Holman University of Oxford
Mark E. Molitch
Mark E. Molitch Northwestern University
William F. Rosenberger
William F. Rosenberger George Mason University
Jerry P. Palmer
Jerry P. Palmer University of Washington

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring the field of Medicine in the USA opens doors to a wide range of online degrees and diverse healthcare career options. For those looking to become a nurse, you can fast-track your journey through absn programs that don't require teas, eliminating some of the most common entrance exam barriers.

If you’re interested in healthcare leadership, accelerated healthcare administration degree programs offer flexible options to quickly prepare for roles in hospital management and policy. Registered nurses aiming to become family nurse practitioners can consider seamless transition pathways with rn to fnp programs, empowering you to serve in more advanced clinical roles.

Additionally, for those passionate about preventive care and wellness, studying with a fully online format in online nutrition degree programs can help launch or advance a career in nutritional science or counseling. These online pathways make healthcare education more accessible and support various interests across the medical field.

Best Scientists Citing John M. Lachin

Trending Scientists

Recently Published Articles